Menu
Not yet recruiting NCT04184583

Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome

Observational Drug Therapy Acute Coronary Syndrome

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Drug Therapy, Acute Coronary Syndrome. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome

Primary outcome measures

  • main adverse cardiovascular and cerebrovascular events (MACCE) [Time frame: up to 5 years]
Secondary outcome measures (1)
  • Adverse drug reaction [Time frame: up to 5 years]

Eligibility criteria

Inclusion criteria

  • Informed consent has been signed.
  • Patients diagnosed in our hospital with acute coronary syndrome.
  • Age ≥18.
  • Life expectancy ≥12 months.

Exclusion criteria

  • Severe lack of important information such as history of previous medication, history of previous disease, history of surgery.
  • Pregnant and lactating women.
  • Mental disorders, or inability to communicate effectively with researchers, or failure to comply with research protocols.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

China · 1 center
  • Beijing Anzhen Hospital — Beijing

Identifiers

NCT: NCT04184583 · ANZHEN HOSPITOL-LY-02

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗